Bioceres Crop Solutions Corp · Q1 2026 earnings

Briefing

Bioceres Q1 FY2026: revenue falls 17% to $77.5M as strategic reset continues, but adjusted EBITDA jumps 61%

Bioceres Crop Solutions reported fiscal first quarter 2026 results for the period ended September 30, 2025, with total revenue of $77.5 million, down 17% year over year as the company deliberately pruned low-margin seed downstream sales and working-capital-intensive products. Despite the top-line decline, gross margin expanded to 47% from 40%, operating profit rose to $7.1 million from $2.4 million, and adjusted EBITDA increased 61% to $13.6 million. Net loss widened slightly to $7.5 million from $6.2 million due to higher financial costs including a $2.7 million accrual related to outstanding notes. Management emphasized improved product mix, cost discipline, and working-capital efficiency while navigating a still-challenging Argentine market.

• Total revenue was $77.5 million, down 17% YoY, reflecting the planned HB4 seed model transition and exit from low-margin sales.
• Gross margin expanded to 47% from 40% and adjusted EBITDA grew 61% to $13.6 million despite lower revenue.
• Operating profit reached $7.1 million, up from $2.4 million in the prior-year quarter, driven by SG&A cuts and mix improvement.
• Net loss was $7.5 million versus $6.2 million as higher interest expense and tax accruals offset operating gains.
• Secured notes were reclassified to current liabilities after a November 2025 acceleration notice, creating going-concern uncertainty.

Headline financials

Revenue & EPS history